JACOBIO-B (01167) receives the down payment under the capital increase agreement and equity transfer agreement.

JACOBIO-B (01167) issued an announcement regarding the capital increase agreement and equity transfer agreement signed with Beijing Jiakebi, Jiake Ruikang, Haicong Capital, and an industrial cooperation partner. The company's board of directors happily announced that its subsidiary Beijing Jiakebi (an indirectly owned non-wholly owned subsidiary) has received the first payment of RMB 125 million from Haicong Capital for the signed capital increase agreement and equity transfer agreement. The receipt of this first payment has further increased the group's cash reserves and will provide support for the advancement of the group's future innovative pipeline research in cancer therapy.